The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Molecular characterization of a peripheral receptor for cannabinoids
Abstract
The major active ingredient of marijuana, delta 9-tetrahydrocannabinol (delta 9-THC), has been used as a psychoactive agent for thousands of years. Marijuana, and delta 9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting. The clinical application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochemical bases of their action. Progress stemmed initially from the synthesis of potent derivatives of delta 9-THC, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids. This receptor is expressed in the brain but not in the periphery, except for a low level in testes. It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins. Here we report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary psychoactive constituent of cannabis, THC (Mechoulam and Gaoni, 1965), and certain other plant-derived or synthetic psychoactive cannabinoids bind cannabinoid (CB 1 and CB 2 ) receptors (Devane et al, 1988;Matsuda et al, 1990;Munro et al, 1993).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Munro et al, 1993
In the citing paper
“CB1 and CB2 receptors exhibit disparate anatomical distributions.3”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [3]
In the citing paper
“Both CB12 and CB23 receptors are G-coupled protein receptors that are negatively coupled to adenylate cyclase.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [3]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Collins, S. (1987) · Blood · doi:10.1182/blood.v70.5.1233.1233 · Cited by 1,189
The probable arrangement of the helices in G protein‐coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 698
An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2
Seed, B. (1987) · Nature · doi:10.1038/329840a0 · Cited by 674
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 660
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., & Civelli, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7432 · Cited by 659
ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM
Simmons, D., Makgoba, M. W., & Seed, B. (1988) · Nature · doi:10.1038/331624a0 · Cited by 616
Research works printed but not linked: 8
- Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
- Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
- Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
- Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
- Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
- Reichman, M., Nen, W. & Hokin, L. E. Molec. Pharmac. 40, 547–555 (1991).
- Munson, A. E. & Fehr, K. O. in Adverse Health and Behavioral Consequences of Cannabis Use (eds Fehr, K. O. & Kalant H.) 257–353 (Addiction Research Foundation, Toronto, 1983).
- Robinson, A. P., White, T. M. & Mason, D. W. Immunology 57, 239–247 (1986).
Cited by
Sorted by citations
Items 901–1,000 of 1,038
Izzo, A. A., Mascolo, N., Borrelli, F., & Capasso, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701964 · Cited by 107
Anhedonia in depression symptomatology: appetite dysregulation and defective brain reward processing
Coccurello, R. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112041 · Cited by 106
Role of Cannabinoids in Multiple Sclerosis
Zajicek, J., & Apostu, V. I. (2011) · CNS Drugs · doi:10.2165/11539000-000000000-00000 · Cited by 106
Couch, D. G., Cook, H., Ortori, C. A., Barrett, D. A., Lund, J. N., & O’Sullivan, S. E. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz017 · Cited by 106
Endocannabinoid System: Chemical Characteristics and Biological Activity
Rezende, B., Alencar, A. K. N., de Bem, G. F., Fontes-Dantas, F. L., & Montes, G. C. (2023) · Pharmaceuticals · doi:10.3390/ph16020148 · Cited by 108
Ford, W. R., Honan, S. A., White, R., & Hiley, C. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704565 · Cited by 107
Amenta, P. S., Jallo, J., Tuma, R. F., & Elliott, M. B. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23114 · Cited by 106
Vrablik, T. L., & Watts, J. L. (2013) · Molecular Reproduction and Development · doi:10.1002/mrd.22167 · Cited by 106
Molina‐Holgado, F., Molina‐Holgado, E., & Guaza, C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00851-5 · Cited by 106
Carroll, C., Zeissler, M., Hanemann, C. O., & Zajicek, J. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01248.x · Cited by 106
Govaerts, S. J., Hermans, E., & Lambert, D. M. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.07.013 · Cited by 107
Targeting cannabinoid agonists for inflammatory and neuropathic pain
Cheng, Y., & Hitchcock, S. A. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.951 · Cited by 105
Cannabidiol as a potential treatment for psychosis
Schubart, C. D., Sommer, I. E., Fusar‐Poli, P., de Witte, L. D., Kahn, R. S., & Boks, M. P. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.002 · Cited by 105
Cannabinoid signaling in health and disease
Lu, Y., & Anderson, H. D. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0346 · Cited by 105
Endocannabinoids in immune regulation and immunopathologies
Rahaman, O., & Ganguly, D. (2021) · Immunology · doi:10.1111/imm.13378 · Cited by 105
Valk, P. J. M., Verbakel, S. E., Vankan, Y., Hol, S., Mancham, S., Ploemacher, R., Mayen, A. E. M., Löwenberg, B., & Delwel, R. (1997) · Blood · doi:10.1182/blood.v90.4.1448 · Cited by 105
Oka, S., Kimura, S., Toshida, T., Ota, R., Yamashita, A., & Sugiura, T. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvp208 · Cited by 105
3D structural model of the G‐protein‐coupled cannabinoid CB2 receptor
Xie, X., Chen, J., & Billings, E. M. (2003) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10511 · Cited by 105
The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility
Karasu, T., Marczylo, T. H., Maccarrone, M., & Konje, J. C. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq058 · Cited by 105
Sierra, S., Luquin, N., Rico, A. J., Gómez-Bautista, V., Roda, E., Dopeso‐Reyes, I. G., Vázquez, A., Martínez‐Pinilla, E., Labandeira-García, J. L., Franco, R., et al. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0823-8 · Cited by 105
Cobellis, G., Cacciola, G., Scarpa, D., Meccariello, R., Chianese, R., Franzoni, M. F., Mackie, K., Pierantoni, R., & Fasano, S. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.106.051730 · Cited by 105
SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist
Portier, M., Rinaldi, M. L., Pecceu, F., Combes, T., Poinot‐Chazel, C., Calandra, B., Barth, F., Fur, G. L., & Casellas, P. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37993-5 · Cited by 106
Prather, P. L., Martin, N. A., Breivogel, C. S., & Childers, S. R. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26511-1 · Cited by 105
Cannabinoid derivatives and the pharmacological management of pain
Lessa, M. A., Cavalcanti, I. L., & Figueiredo, N. V. (2016) · Revista Dor · doi:10.5935/1806-0013.20160012 · Cited by 104
Westphal, M. V., Schafroth, M. A., Sarott, R. C., Imhof, M. A., Bold, C. P., Leippe, P., Dhopeshwarkar, A., Grandner, J. M., Katritch, V., Mackie, K., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b06456 · Cited by 104
Applications of Knoevenagel condensation reaction in the total synthesis of natural products
Heravi, M. M., Janati, F., & Zadsirjan, V. (2020) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-020-02586-6 · Cited by 104
Cannabis sativa research trends, challenges, and new-age perspectives
Hussain, T., Jeena, G., Pitakbut, T., Vasilev, N. P., & Kayser, O. (2021) · iScience · doi:10.1016/j.isci.2021.103391 · Cited by 104
Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors
Hanu, L. O., Tchilibon, S., Ponde, D. E., Breuer, A., Fride, E., & Mechoulam, R. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b416943c · Cited by 104
Endocannabinoids: A unique opportunity to develop multitarget analgesics
Maione, S., Costa, B., & Marzo, V. D. (2013) · Pain · doi:10.1016/j.pain.2013.03.023 · Cited by 104
Marijuana: Respiratory Tract Effects
Owen, K. P., Sutter, M. E., & Albertson, T. E. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8374-y · Cited by 104
Herrera, B. M., Carracedo, A., Diez-Zaera, M., del Pulgar, T. G., Guzmán, M., & Velasco, G. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.009 · Cited by 104
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids
Puighermanal, E., Busquets-García, A., Maldonado, R. J., & Ozaita, A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0384 · Cited by 104
Fimiani, C., Mattocks, D. A. L., Cavani, F., Salzet, M., Deutsch, D. G., Pryor, S. C., Bilfinger, T. V., & Stefano, G. B. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(98)00060-6 · Cited by 104
Kim, J., & Li, Y. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.286633 · Cited by 103
Endocannabinoid system and pregnancy
Corrêa, F. M. D. A., Wolfson, M. L., Valchi, P., Aisemberg, J., & Franchi, A. M. (2016) · Reproduction · doi:10.1530/rep-16-0167 · Cited by 103
Thapa, D., Cairns, E. A., Szczesniak, A.-M., Toguri, J. T., Caldwell, M. D., & Kelly, M. E. M. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0041 · Cited by 103
Veilleux, A., Marzo, V. D., & Silvestri, C. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1248-9 · Cited by 105
The cannabinoid system and microglia in health and disease
Duffy, S. S., Hayes, J. P., Fiore, N. T., & Moalem‐Taylor, G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108555 · Cited by 103
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
Abate, G., Uberti, D. L., & Tambaro, S. (2021) · Biology · doi:10.3390/biology10060542 · Cited by 103
Vascular targets for cannabinoids: animal and human studies
Stanley, C. P., & O’Sullivan, S. E. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12560 · Cited by 103
Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study
Montero, C., Campillo, N. E., Goya, P., & Paez, J. A. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.10.002 · Cited by 103
Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease
García, M. C., Cinquina, V., Palomo‐Garo, C., Rábano, A., & Fernández‐Ruíz, J. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.003 · Cited by 103
Nackley, A. G., Suplita, R. L., & Hohmann, A. G. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00870-9 · Cited by 103
Marsicano, G., & Kuner, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_10 · Cited by 103
Time course for the induction and maintenance of tolerance to Δ9-tetrahydrocannabinol in mice
Bass, C. E., & Martin, B. R. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00150-7 · Cited by 103
Involvement of cannabinoid receptors in gut motility and visceral perception
Hornby, P. J., & Prouty, S. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705783 · Cited by 103
Yu, X. H., Cao, C. Q., Martino, G., Puma, C., Morinville, A., St-Onge, S., Lessard, É., Perkins, M., & Laird, J. M. A. (2010) · Pain · doi:10.1016/j.pain.2010.07.019 · Cited by 102
Reddy, D. S. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114237 · Cited by 102
Ellert‐Miklaszewska, A., Grajkowska, W., Gabrusiewicz, K. R., Kaminska, B., & Konarska, L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.060 · Cited by 102
Pei, Y., Mercier, R. W., Anday, J. K., Thakur, G. A., Zvonok, A. M., Hurst, D. P., Reggio, P. H., Janero, D. R., & Makriyannis, A. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.011 · Cited by 102
Guindon, J., Desroches, J., & Beaulieu, P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706990 · Cited by 102
Jia, W., Hegde, V. L., Singh, N. P., Sisco, D., Grant, S., Nagarkatti, M., & Nagarkatti, P. S. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0193 · Cited by 102
Sánchez, C., Rueda, D., Ségui, B., Galve‐Roperh, I., Levade, T., & Guzmán, M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.955 · Cited by 102
Husni, A. S., McCurdy, C. R., Radwan, M. M., Ahmed, S. A., Slade, D., Ross, S. A., ElSohly, M. A., & Cutler, S. J. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-0972-6 · Cited by 101
Abadji, V., Lucas-Lenard, J. M., Chin, C., & Kendall, D. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722032.x · Cited by 101
Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions
Mendizábal, V. E., & Adler‐Graschinsky, E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707261 · Cited by 101
Effects of cannabis on cognitive function in patients with multiple sclerosis
Honarmand, K., Tierney, M. C., O'Connor, P. W., & Feinstein, A. (2011) · Neurology · doi:10.1212/wnl.0b013e318212ab0c · Cited by 101
New class of potent ligands for the human peripheral cannabinoid receptor
Gallant, M., Dufresne, C., Gareau, Y., Guay, D., Leblanc, Y., Prasit, P., Rochette, C., Sawyer, N., Slipetz, D. M., Tremblay, N. M., et al. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00426-x · Cited by 101
Derocq, J., Jbilo, O., Bouaboula, M., Ségui, M., Clère, C., & Casellas, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15621 · Cited by 101
Tao, Q., & Abood, M. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37469-5 · Cited by 101
Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
Beaulieu, P., Bisogno, T., Punwar, S., Farquhar-Smith, W. P., Ambrosino, G., Marzo, V. D., & Rice, A. S. C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00226-0 · Cited by 101
Ouyang, Y., Hwang, S. G., Han, S. H., & Kaminski, N. E. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.676 · Cited by 101
Wong, B. S., Camilleri, M., Busciglio, I., Carlson, P., Szarka, L. A., Burton, D., & Zinsmeister, A. R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.036 · Cited by 100
Large Receptor Reserve for Cannabinoid Actions in the Central Nervous System
Gifford, A. N., Bruneus, M., Gatley, S. J., Lan, R., Makriyannis, A., & Volkow, N. D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37979-0 · Cited by 100
Hwang, J., Adamson, C. L., Butler, D., Janero, D. R., Makriyannis, A., & Bahr, B. A. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.06.003 · Cited by 100
Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System
Augustin, S. M., & Lovinger, D. M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00508 · Cited by 100
Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth
DeMorrow, S., Glaser, S. S., Francis, H., Venter, J. K., Vaculin, B. T., Vaculin, S., & Alpini, G. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608238200 · Cited by 100
Lee, S. F., Newton, C. A., Widen, R. E., Friedman, H. P., & Klein, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01122-0 · Cited by 100
Straiker, A. J., Hu, S. S., Long, J. Z., Arnold, A., Wager‐Miller, J., Cravatt, B. F., & Mackie, K. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059030 · Cited by 100
Romero, J., García‐García, L., Fernández‐Ruíz, J., Cebeira, M., & Ramos, J. A. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00023-p · Cited by 100
Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes
Wiley, J. L., & Martin, B. R. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00146-9 · Cited by 100
Fatty Acid Amide Hydrolase: A Gate-Keeper of the Endocannabinoid System
Fezza, F., De Simone, C., Amadio, D., & Maccarrone, M. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_4 · Cited by 99
Marijuana use and testicular germ cell tumors
Trabert, B. L., Sigurdson, A. J., Sweeney, A., Strom, S. S., & McGlynn, K. A. (2010) · Cancer · doi:10.1002/cncr.25499 · Cited by 99
Kargl, J., Balenga, N. A. B., Parzmair, G. P., Brown, A. J., Heinemann, Á., & Waldhoer, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.364109 · Cited by 99
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors
Mukherjee, S., Adams, M., Whiteaker, K. L., Daza, A. V., Kage, K., Cassar, S. C., Meyer, M., & Yao, B. B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.058 · Cited by 99
Cannabinoids, Immune System and Cytokine Network
Massi, P., Vaccani, A., & Parolaro, D. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777947425 · Cited by 99
Nasser, M. W., Qamri, Z., Deol, Y. S., Smith, D. L., Shilo, K., Zou, X., & Ganju, R. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023901 · Cited by 99
Järbe, T. U. C., Andrzejewski, M. E., & DiPatrizio, N. V. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00938-3 · Cited by 99
Inhibition of pain responses by activation of CB2 cannabinoid receptors
Malan, T. P., Ibrahim, M. M., Vanderah, T. W., Makriyannis, A., & Porreca, F. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00155-x · Cited by 99
Phytocannabinoids in Cannabis sativa: Recent Studies on Biosynthetic Enzymes
Taura, F., Sirikantaramas, S., Shoyama, Y., Shoyama, Y., & Morimoto, S. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790145 · Cited by 98
Alvheim, A. R., Torstensen, B. E., Lin, Y. H., Lillefosse, H. H., Lock, E., Madsen, L., Frøyland, L., Hibbeln, J. R., & Kjellevold, M. (2013) · Lipids · doi:10.1007/s11745-013-3842-y · Cited by 98
Jha, N. K., Sharma, C., Hashiesh, H. M., Arunachalam, S., Meeran, M. F. N., Javed, H., Patil, C. R., Goyal, S. N., & Ojha, S. K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.590201 · Cited by 98
Molecules in blastocyst implantation: Uterine and embryonic perspectives
Lim, H. J., Song, H., Paria, B. C., Reese, J., Das, S., & Dey, S. K. (2002) · Vitamins and hormones · doi:10.1016/s0083-6729(02)64002-6 · Cited by 98
Wang, H., Xie, H., Sun, X., Kingsley, P. J., Marnett, L. J., Cravatt, B. F., & Dey, S. K. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.09.009 · Cited by 98
Lipid Signaling and Synaptic Plasticity
Sang, N., & Chen, C. (2006) · The Neuroscientist · doi:10.1177/1073858406290794 · Cited by 98
The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy
Taylor, A. H., Ang, C., Bell, S. C., & Konje, J. C. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm018 · Cited by 98
Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration
Basavarajappa, B. S., Nixon, R. A., & Arancio, O. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787847921 · Cited by 98
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Nguyen, T., Li, J., Thomas, B. F., Wiley, J. L., Kenakin, T., & Zhang, Y. (2016) · Medicinal Research Reviews · doi:10.1002/med.21418 · Cited by 98
The CB1 Receptor as the Cornerstone of Exostasis
Piazza, P. V., Cota, D., & Marsicano, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.002 · Cited by 100
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 98
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528
Shire, D. J., Calandra, B., Bouaboula, M., Barth, F., Rinaldi, M. L., Casellas, P., & Ferrara, P. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00285-4 · Cited by 98
Patsos, H. A. (2005) · Gut · doi:10.1136/gut.2005.073403 · Cited by 98
Rinaldi, M. L., Duigou, A. L., Oustric, D., Barth, F., Bouaboula, M., Carayon, P., Casellas, P., & Fur, G. L. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37898-x · Cited by 98
Mauler, F., Mittendorf, J., Horváth, E., & Vry, J. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.359 · Cited by 98
From cannabis to cannabinergics
Goutopoulos, A., & Makriyannis, A. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00250-4 · Cited by 98
Stefano, G. B. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00223-3 · Cited by 98
Elmes, S. J. R., Winyard, L. A., Medhurst, S. J., Clayton, N. M., Wilson, A. W., Kendall, D. A., & Chapman, V. (2005) · Pain · doi:10.1016/j.pain.2005.09.005 · Cited by 97
Clarke, J. R., Rossato, J. I., Monteiro, S., Bevilaqua, L. R. M., Izquierdo, I., & Cammarota, M. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.04.009 · Cited by 97
Savonenko, A. V., Melnikova, T., Wang, Y., Ravert, H. T., Gao, Y., Koppel, J. L., Lee, D., Pletniková, O., Cho, E., Sayyida, N., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129618 · Cited by 97
Pinsger, M., Schimetta, W., Volc, D., Hiermann, E., Riederer, F., & Pölz, W. (2006) · Wiener klinische Wochenschrift · doi:10.1007/s00508-006-0611-4 · Cited by 96
Metadata
- Authors
- Munro, S., Thomas, K. L., & Abu-Shaar, M.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Venue
- Nature
- Published
- 1993-09
- Volume
- 365
- Issue
- 6441
- Pages
- 61-65
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2056188558
- Cited by
- 5,092
- References
- 30
- Citations by year
- 2026: 76 · 2025: 119 · 2024: 165 · 2023: 172 · 2022: 198 · 2021: 244 · 2020: 212 · 2019: 184 · 2018: 169 · 2017: 188 · 2016: 182 · 2015: 175 · 2014: 188 · 2013: 201 · 2012: 202
- FWCI
- 39.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- cannabinoid receptors, delta-9-tetrahydrocannabinol, peripheral cannabinoid receptors, macrophages, receptor cloning, G protein-coupled receptors, immunosuppression, anti-inflammatory activity
- MeSH terms
- Amides, Amino Acid Sequence, Animals, Arachidonic Acids, Base Sequence, Brain, Cannabinoids, Cloning, Molecular, DNA, Fatty Acids, Unsaturated, Humans, Macrophages, Molecular Sequence Data, Morpholines, Naphthalenes, Receptors, Drug, RNA, Spleen, Tumor Cells, Cultured, Receptors, Cannabinoid, Benzoxazines, Rats, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review